A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT)

Saved in:
Bibliographic Details
Other Authors: Teal, Philip (Other) , Hacke, Werner (Other) , Hennerici, Michael G. (Other)
Format: Article (Journal)
Language:English
Published: 2009
In: Stroke
Year: 2009, Volume: 40, Issue: 11, Pages: 3518-25
ISSN:1524-4628
DOI:10.1161/STROKEAHA.109.551382
Online Access:Verlag, Volltext: http://dx.doi.org/10.1161/STROKEAHA.109.551382
Resolving-System, Volltext: http://stroke.ahajournals.org/content/40/11/3518.full.pdf+html
Get full text
Author Notes:Philip Teal ... W. Hacke ...
Description
Item Description:Gesehen am 21.11.2014
Advisory board: A. Davalos, Girona, Spain; L. B. Goldstein, Durham, NC; D. F. Hanley, Baltimore, Md; M. Hennerici, Mannheim, Germany; G. L. Lenzi, Rome, Italy; J. M. Orgogozo, Bordeaux, France; R. Sacco, New York, NY
Physical Description:Online Resource
ISSN:1524-4628
DOI:10.1161/STROKEAHA.109.551382